Amgen says jury couldn't properly find against it in Regeneron's US antitrust case
MLex Summary: Amgen asked a US federal judge to enter a judgment in its favor after a jury awarded Regeneron damages in an antitrust suit over cholesterol-reducing medication, saying Regeneron offered...To view the full article, register now.
Already a subscriber? Click here to view full article